Suppr超能文献

首例人体试验:采用球囊介导的消融技术预防瓣中瓣经导管主动脉瓣置换术中的冠状动脉阻塞(LLAMACORN),通过射频消融针撕裂二尖瓣瓣叶。

First-in-human: Leaflet laceration with balloon mediated annihilation to prevent coronary obstruction with radiofrequency needle (LLAMACORN) for valve-in-valve transcatheter aortic valve replacement.

机构信息

Department of Cardiology, Princess Alexandra Hospital, Brisbane, Australia.

Faculty of Medicine, University of Queensland, Brisbane, Australia.

出版信息

Catheter Cardiovasc Interv. 2024 Nov;104(5):1079-1085. doi: 10.1002/ccd.31195. Epub 2024 Sep 3.

Abstract

Coronary obstruction (CO) is a potential pitfall for transcatheter aortic valve replacement (TAVR), especially in valve in valve procedures into degenerated surgical or transcatheter prostheses. Bioprosthetic leaflet modification techniques that incorporate electrosurgery are evolving as the preferred strategy to mitigate the risk of CO in high CO risk settings. The UNICORN method is proposed as a more predictable leaflet modification strategy than the earlier described BASILICA approach, but its proponents have hitherto mandated the use of a balloon-expandable valve (BEV) prosthesis. Many patients have small prostheses and therein face a significant risk of patient prosthesis mismatch with BEV in this setting. This risk may be curtailed if a self-expanding valve (SEV) prosthesis could be used. Herein described is a modified approach to allow for the utilization of SEV systems in this setting.

摘要

冠状动脉阻塞(CO)是经导管主动脉瓣置换术(TAVR)的潜在陷阱,特别是在退行性外科或经导管假体的瓣中瓣手术中。结合电外科的生物瓣叶修正技术正在发展成为降低高 CO 风险情况下 CO 风险的首选策略。UNICORN 方法被提议作为一种比早期描述的 BASILICA 方法更可预测的瓣叶修正策略,但它的支持者迄今一直要求使用球囊扩张瓣膜(BEV)假体。许多患者的假体较小,在此情况下,他们面临着与 BEV 发生患者假体不匹配的重大风险。如果可以使用自扩张瓣膜(SEV)假体,则可以降低这种风险。本文描述了一种改良方法,允许在此情况下使用 SEV 系统。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验